Antimicrobial treatment in invasive infections caused by
Gordonia bronchialis
antimicrobial treatment
ciprofloxacin
invasive infections
vancomycin
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2024
2024
Historique:
received:
05
11
2023
accepted:
13
02
2024
medline:
22
3
2024
pubmed:
22
3
2024
entrez:
22
3
2024
Statut:
epublish
Résumé
Corynebacterium, Nocardia, Rhodococcus, Mycobacterium, as well as Gordonia genera belongs to the genus Gordonia, Actinomycetia class. We have registered this systematic review in PROSPERO database of systematic reviews and meta-analyses with the number CRD42022369974. A total of 24 publications were included (22 case reports and two case series) with 28 individual cases. The oldest patients had 92 years, and the youngest patients had 13 years. Clinical signs of infection were present in six patients (21%). All isolates were susceptible to ciprofloxacin, imipenem, and amikacin. Vancomycin was the most frequently used antibiotic with nine cases followed by ciprofloxacin, ceftriaxone, and amoxicillin/clavulanic acid. Although there are no standardized recommendations to date, successful treatment with a favorable outcome has most often been carried out with fluoroquinolones, vancomycin with or without aminoglycosides, as well as carbapenems.
Sections du résumé
Background
UNASSIGNED
Corynebacterium, Nocardia, Rhodococcus, Mycobacterium, as well as Gordonia genera belongs to the genus Gordonia, Actinomycetia class.
Methods
UNASSIGNED
We have registered this systematic review in PROSPERO database of systematic reviews and meta-analyses with the number CRD42022369974.
Results
UNASSIGNED
A total of 24 publications were included (22 case reports and two case series) with 28 individual cases. The oldest patients had 92 years, and the youngest patients had 13 years. Clinical signs of infection were present in six patients (21%). All isolates were susceptible to ciprofloxacin, imipenem, and amikacin. Vancomycin was the most frequently used antibiotic with nine cases followed by ciprofloxacin, ceftriaxone, and amoxicillin/clavulanic acid.
Conclusion
UNASSIGNED
Although there are no standardized recommendations to date, successful treatment with a favorable outcome has most often been carried out with fluoroquinolones, vancomycin with or without aminoglycosides, as well as carbapenems.
Identifiants
pubmed: 38515988
doi: 10.3389/fmed.2024.1333663
pmc: PMC10957228
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
1333663Informations de copyright
Copyright © 2024 Zivkovic Zaric, Canovic, Zaric, Vuleta, Vuleta Nedic, Jovanovic, Zornic, Nesic, Spasic, Jakovljevic, Ilic, Jovanovic, Todorovic, Arsenijevic, Sovrlic and Milovanovic.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.